The influence of EPA and DHA on markers of inflammation in 3T3-L1 cells at different stages of cellular maturation by Adam Prostek et al.
Prostek et al. Lipids in Health and Disease 2014, 13:3
http://www.lipidworld.com/content/13/1/3RESEARCH Open AccessThe influence of EPA and DHA on markers of
inflammation in 3T3-L1 cells at different stages of
cellular maturation
Adam Prostek*, Małgorzata Gajewska, Dariusz Kamola and Bożena BałasińskaAbstract
Background: EPA and DHA have been reported to have anti-obesity and anti-inflammatory properties. Recent
studies revealed that these positive actions of n-3 PUFA at least partially are connected with their influence on
metabolism and secretory functions of the adipose tissue. However, their impact on old adipocytes is still poorly
understood. Therefore the aim of the present study was to evaluate the influence of EPA and DHA on markers of
inflammation in 3T3-L1 cells at different stages of cellular maturation.
Methods: Young, mature and old differentiated 3T3-L1 adipocytes were cultured for 48 h in the presence of
100 μM EPA, or 50 μM DHA complexed to albumin, whereas in control conditions only albumin was added to the
medium. The Oil Red O staining was used to confirm adipocytes differentiation, and measure triglycerides content
in cells. The concentration of adipokines (interleukin 6, adiponectin and leptin) in conditioned media was measured
using mouse-specific ELISA kits.
Results: The fat accumulation in 3T3-L1 adipocytes was positively correlated with their age; however, EPA and DHA
did not affect lipid accumulation on any stage of maturation. EPA and DHA increased the concentration of secreted
adiponectin when compared with control, but only in the case of young adipocytes (58% and 35%, respectively).
Moreover, EPA supplementation increased interleukin 6 concentration in conditioned medium, while DHA exerted
an opposite effect on all stages of cellular maturation. Furthermore, EPA treatment increased leptin release from
young cells, while DHA did not affect the secretion of this adipokine. In mature 3T3-L1 adipocytes both experimental
factors decreased synthesis of leptin; however, in old cells no impact of these PUFA was noted.
Conclusions: In summary, age is an important determinant of fat accumulation in adipocytes and affects adipokines
secretion by these cells. Moreover, the impact of investigated fatty acids: EPA and DHA on fat cells varies depending on
the stage of maturation, and seems to be stronger in young cells than in mature and old ones. Docosahexaenoic acid
exerts an anti-inflammatory action; however, on the basis of the obtained data it was not possible to determine
whether eicosapentaenoic acid shows anti- or pro-inflammatory properties.
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In recent years long chain polyunsaturated fatty acids n-
3 (LC-PUFA n-3), such as eicosapentaenoic acid (EPA;
C20:5; n-3) and docosahexaenoic acid (DHA; C22:6; n-3)
are a subject of interest of many research centres around
the world because of their beneficial effects on human
and animal health. The most important positive actions
of LC-PUFA n-3 are reduction of risk of cardiovascular
diseases, cancer and dementia (Alzheimer’s disease)
[1-3]. EPA and DHA have been reported to have protect-
ive effects in many types of chronic inflammatory condi-
tions, such as: rheumatoid arthritis, asthma, Crohn’s
disease and psoriasis [4]. The anti-inflammatory actions of
n-3 PUFA are connected with their ability to decrease pro-
duction of pro-inflammatory eicosanoids and cytokines
[5]. Moreover, they are substrates for synthesis of other
lipid mediators, such as anti-inflammatory protectins and
resolvins [6].
Obesity is connected with increased immune activation
and chronic state of low-grade inflammation in adipose tis-
sue [7]. Low-grade inflammation in adipose tissue causes
dysregulation of secretion of pro- and anti-inflammatory
adipokines. Numerous recent studies have shown that se-
cretion of proinflammatory cytokines (interleukin 6, TNF
Alpha, MCP – 1, leptin) is increased in obesity; whereas,
the concentration of anti-inflammatory cytokines (adipo-
nectin, interleukin 10) is decreased [8-10]. The exact
mechanism of inflammation in adipose tissue associated
with obesity is still unclear. It is assumed that hypoxia [11]
or endoplasmic reticulum stress (ER stress) [12] can play
role in development of this anomaly.
The impact of EPA and DHA on adipose tissue metab-
olism, and their role in obesity prevention have gained
an increasing attention in recent years [13]. It was ob-
served that treatment of obese subjects with n-3 PUFA
led to reduced circulating levels of pro-inflammatory
cytokines and acute phase proteins [14]. In vitro and
in vivo studies have revealed that these positive actions
of n-3 PUFA at least partially are connected with their
influence on metabolism and secretory functions of adi-
pose tissue [15]. In most cases investigated fatty acids
decreased secretion of pro-inflammatory adipokines, and
increased synthesis of anti-inflammatory adipokines by
adipose tissue cells.
Aging is associated with fat mass accretion [16]. Stor-
ing excess fat in adipocytes leads to their hypertrophy,
and stimulates differentiation of new fat cells. However,
it was demonstrated that the proliferation of preadipo-
cytes and their ability to differentiate decreases with age
in rats [17]. Furthermore, several recent studies have
suggested that increased secretion of pro-inflammatory
adipokines by adipocytes is positively correlated with cell
aging [18,19] and their size [20]. These observations sug-
gest that the metabolism and functions of mature andold adipocytes may play an important role in health sta-
tus regulation, considering the fact that they constitute a
large part of the fat tissue, especially in older individuals.
The 3T3-L1 cells are a recognized in vitro model of adi-
pogenesis. Results of many studies revealed that n-3
PUFA can affect metabolism and markers of inflammation
in this type of cells. However, the effect of LC-PUFA n-3
on adipocytes on later stages of cellular maturation is still
unknown. Therefore, the aim of the present study was to
evaluate the influence of EPA and DHA on markers of in-
flammation in 3T3-L1 cells on different stages of cellular
maturation.
Results
Effects of EPA and DHA on lipid accumulation and lipolysis
Oil Red O was extracted from adipocytes and absorbance
was measured to evaluate triglyceride contents in cells.
The accumulation of lipids in differentiated 3T3-L1 cells
was positively correlated with the day of culture (Figure 1).
However, examined polyunsaturated fatty acids EPA and
DHA did not affect lipid accumulation on any stage of
maturation. Glycerol release was measured to deter-
mine the influence of EPA and DHA on the intensity of
lipolysis in cultured adipocytes. Experimental factors
had no impact on lipolysis in used concentrations (that
constituted the highest concentrations showing no toxic
effect in the cells, as evaluated in a preliminary study –
data not shown).
Effects of EPA and DHA on adipokines secretion
by 3T3-L1 adipocytes
Age of cells (days post-induction of in vitro differenti-
ation – PID) had a significant impact on secretion of
adipokines. Concentration of pro-inflammatory cyto-
kines was increased in conditioned medium of adipo-
cytes from the 12th and 16th day of culture (PID) in
comparison with the cells from the 8th day. Further-
more, the cells from the long-term culture secreted
lower amounts of anti-inflammatory proteins. Time-
dependent changes are presented in Table 1.
ELISA tests also revealed that both investigated poly-
unsaturated fatty acids increased the concentration of
secreted adiponectin when compared with control (58%
and 35%, respectively), but only on the early stage of
maturation (PID 8). On PID 12 and 16 this effect was
not observed (Figure 2).
Moreover, as shown in Figure 3, EPA supplementation
increased interleukin 6 concentration in conditioned
medium, while DHA exerted an opposite effect. In the
case of interleukin 6 similar impact of examined fatty
acids was observed on PIDs 8,12 and 16.
The influence of investigated n-3 PUFA on leptin secre-
tion varied on different stages of maturation. On PID 8
EPA significantly increased leptin release form adipocytes,
Figure 1 Lipid accumulation in 3T3-L1 cells at different time of culture (days post induction of differentiation – PID). (A) pictures from
phase-contrast microscopy of cells stained with Oil red O on PID 8,12 and 16. (B) Absorbance of Oil red O extracted from 3T3-L1 cells on PID 8,
12 and 16.
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On later days of culture (PID 12) both experimental fac-
tors decreased synthesis of leptin; however, on PID 16 no
impact of these PUFA was noted (Figure 4).
Cellular fatty acids content
The content of investigated fatty acids: EPA and DHA in
cells was quantified using GC-MS. The analysis showed
that EPA and DHA uptake is age-dependent. The con-
tent of both fatty acids in cultured cells was the lowest
on PID 8 and the highest on PID 16 (Figure 5). However,
the content of examined EPA and DHA presented as the
percentage of total fatty acids in cultured cells showed
an opposite trend (Table 2).
Discussion
In our experiment we hypothesized that the size of adipo-
cytes is an important determinant of the adipokine secre-
tion profiles. Accordingly, the large adipocytes released
more pro-inflammatory and less anti-inflammatory adipo-
kines than the lean fat cells. Studies have shown that large
adipocytes are characteristic for adipose tissue of obeseTable 1 Secretion of adipokines by 3T3-L1 cells during ageing
PID 8
Adiponectin concentration (ng/ml) ± SEM 1443.12 ± 31.52a
IL-6 concentration (pg/ml) ± SEM 33.41 ± 1.96a
Leptin concentration (pg/ml) ± SEM 91.33 ± 13.02a
Data are presented as means ± SEM, n = 3. Values in the same row that do not sha
to one-way ANOVA (P < 0.05).individuals. Moreover, obesity is more common in older
people, in whom the ability of new adipocytes to differen-
tiate is significantly decreased. There is a lack of informa-
tion about inflammatory activity in old fat cells because in
most of in vitro studies researchers use young adipocytes,
in which the state of inflammation is induced by LPS
treatment. In our study we used 3T3-L1 cells on different
stages of growth and differentiation. Adipocytes on post-
induction day 8 (PID 8) were considered as young, on PID
12 as mature, and on PID 16 as old. We noted time-
dependent changes in control cells, which were main-
tained in standard medium without experimental factors.
We observed that age of cultured cells was positively
correlated with their fat accumulation. In addition, the
presented results revealed significantly increased secretion
of IL-6 (pro-inflammatory cytokine) by old adipocytes
(PID 16) in comparison with young fat cells (PID 8). Fur-
thermore, secretion of adiponectin (anti-inflammatory
cytokine) was significantly decreased on PID 16 in com-
parison with PID 12. Thus, ageing of adipocytes can cause
their large size and higher release of pro-inflammatory
adipokines. Presented results are in agreement with a(on days 8, 12, 16 post-induction of differentiation-PID)
PID 12 PID 16
3870.25 ± 463.10b 2557.54 ± 104.90c
122.30 ± 5.63b 738.54 ± 42.52c
562.40 ± 16.94b 436.21 ± 47.80c
re the same superscript letter (eg. a, b or c) are significantly different according
Figure 2 Effects of EPA and DHA on secretion of adiponectin
by 3T3-L1 adipocytes. Concentration of adiponectin was measured
in culture media collected on 8th, 12th, and 16th day post-induction
of differentiation (PID 8,12 and 16). Data are presented as means ±
SEM, n = 3. Means without a common letter differ, P < 0.05.
Figure 3 Effects of EPA and DHA on secretion of leptin
by 3T3-L1 adipocytes. Concentration of leptin was measured in
culture media collected on 8th, 12th, and 16th day post-induction of
differentiation (PID 8,12 and 16). Data are presented as means ± SEM,
n = 3. Means without a common letter differ, P < 0.05.
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showed similar correlations [19]. These observations sug-
gest that differentiated 3T3-L1 cells on the later stages of
maturation can constitute a good experimental model for
studying obesity and inflammation in adipose tissue.Our study also aimed at evaluating the influence of EPA
and DHA, which are regarded as PUFA with potential
anti-obesity and anti-inflammatory properties, on fat cells
secretory activities in relation to their age (days of culture).
To our knowledge this is the first study investigating the
Figure 4 Effects of EPA and DHA on secretion of IL-6 by 3T3-L1
adipocytes. Concentration of IL-6 was measured in culture media
collected on 8th, 12th, and 16th day post-induction of differentiation
(PID 8,12 and 16). Data are presented as means ± SEM, n = 3. Means
without a common letter differ, P < 0.05.
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experiment did not reveal any differences in the intensity
of lipolysis (glycerol release) and fat accumulation (Oil red
O absorbance) between adipocytes treated with EPA,
DHA and control cells. These results are contrary toprevious findings showing that both EPA and DHA may
increase lipolysis in differentiated 3T3-L1 cells [21-23].
However, it is hard to compare our data with the cited
studies, in which the doses of evaluated fatty acids were
higher, and the time of exposure was shorter. We used
higher concentrations of EPA (300 μmol/l) and DHA (100,
200 μmol/l) in our preliminary studies, but these doses
caused increased cell death (data not shown). Our obser-
vations indicate that the anti-obesity properties of n-3
PUFA are not connected with their influence on lipolysis
in adipocytes, but possibly with induction of apoptosis in
these cells.
Although we did not observe any effect of EPA and
DHA on lipolysis and fat accumulation, we noted their
significant role in secretion of adipokines by adipocytes
on different stages of maturation. First adipokine inves-
tigated in our study was adiponectin, belongs to the
anti-inflammatory adipokines secreted by adipose tissue,
mainly by adipocytes. In organisms this protein is involved
in i.e. glucose metabolism, fatty acids β-oxidation and in-
sulin sensitivity [24]. Numerous studies have shown that
in obese humans and animals with insulin resistance, con-
centration of plasma adiponectin is significantly decreased.
Moreover, increased endogenous production of this hor-
mone improves insulin sensitivity [25]. In the last few
years, several studies have suggested that n-3 PUFA are
able to decrease insulin resistance connected with obesity,
possibly through their stimulatory effect on adiponectin
secretion. However, the influence of examined fatty acids
on synthesis of this protein by adipocytes is still unclear.
Recent data from in vivo experiments on rodents seem to
confirm the abovementioned thesis. On the other hand,
in vitro studies provided contrary information on this sub-
ject. Kalupahana and co-workers performed an experi-
ment on mice, as well as 3T3-L1 cell line, and revealed
that diet supplementation with EPA improved adiponectin
levels in blood of obese mice, but the authors did not ob-
serve any influence of EPA (150 μM) treatment on adipo-
nectin release by differentiated 3T3-L1 cells [26]. Findings
of another group showed that both EPA and DHA
(250 μM) were able to decrease the expression of apM1
gene, which encodes adiponectin [27]. Our study demon-
strated that investigated n-3 PUFA (EPA 100 μM, DHA
50 μM) increased adiponectin secretion by 3T3-L1 adipo-
cytes, but only on the early stage of maturation (PID 8).
These results are partially in agreement with the study by
Oster and co-workers, who observed similar effects of
EPA and DHA in young cells [28]. However, our experi-
ment showed that the stimulatory activity of both PUFA
on adiponectin secretion by adipocytes was not sustained
on the later days of culture (PID 12 and PID 16). Different
findings of in vitro experiments performed on young fat
cells could be explained by various doses used in both
studies. Oster et. al [28] suggested that high concentrations
Figure 5 Cellular content of EPA or DHA in 3T3-L1 cells during ageing. Uptake of EPA or DHA by 3T3-L1 cells was measured on 8th, 12th, and
16th day post-induction of differentiation (PID 8,12 and 16). Data are presented as means ± SEM, n = 3. Means without a common letter differ, P < 0.05.
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tion in adipocytes, and development of oxidative stress
associated with reduction of adiponectin gene expression.
We also examined the concentration of leptin released
by 3T3-L1 adipocytes. White adipose tissue is the main
source of this hormone in the organism, but it is also se-
creted by stomach, brain and bone morrow [29]. This
adipokine has a systemic action and is engaged in the
regulation of food intake, energy expenditure, body fat
storage and insulin signalling [30]. Moreover, high blood
concentrations of leptin are strongly correlated with
obesity, and it was observed that these concentrations
decrease with weight loss. Several reports, based on
in vitro and in vivo experiments, revealed that n-3 PUFA
are able to modulate leptin secretion by adipocytes. In
our study we demonstrated a stimulatory effect of EPA sup-
plementation on this hormone release by young (PID 8)
3T3-L1 adipocytes, but at this stage DHA did not show any
impact. In the later period of cell culture we observed that
both EPA and DHA significantly decreased secretion of lep-
tin by cells on PID 12, but this effect was not noted on PID
16. The stimulation of leptin secretion by EPA observed on
PID 8 was in agreement with other in vitro studies, showing
that this fatty acid is able to increase leptin gene expression
and leptin secretion in 3T3-L1 cells, as well as primary cul-
tures of rat adipocytes [30,31]. In contrast, Reseland andTable 2 Investigated fatty acids content as the
percentage of total fatty acids in 3T3-L1 cells
during ageing
PID 8 PID 12 PID 16
EPA content as the
percentage of total
fatty acids in EPA
treated groups ± SEM
3.07 ± 0.15%a 3.97 ± 0.27%b 2.45 ± 0.15%c
DHA content as the
percentage of total
fatty acids in DHA
treated groups ± SEM
0.36 ± 0.05%a 0.27 ± 0.02%b 0.16 ± 0.01%c
Data are presented as means ± SEM, n = 3. Values in the same row that do
not share the same superscript letter (eg. a, b or c) are significantly different
according to one-way ANOVA (P < 0.05).co-workers reported that EPA and DHA decreased leptin
mRNA expression in vitro and in vivo [32]. However, the
results obtained by Reseland group are incomparable with
our findings, because they used much higher doses of n-3
PUFA (500 μM). Other in vivo studies also showed that
long-term diet supplementation with n-3 PUFA, resulted in
decreased plasma leptin concentrations in rats and mice
[32,33]. This inhibitory effect observed in vivo is usually
correlated with the anti-obesity influence of n-3 PUFA. To
our knowledge, this is the first report in which the influence
of EPA and DHA on leptin secretion has been investigated
in 3T3-L1 adipocytes on different stages of cellular matur-
ation. Our observations showing the opposite effects of
these fatty acids on leptin secretion between PID 8 and PID
12, and no impact on PID 16 indicate that adipocytes reac-
tion and sensitivity to EPA and DHA are age-dependent.
We also examined the influence of n-3 PUFA on se-
cretion of interleukin 6 (IL-6) by 3T3-L1 cells during
their aging. IL-6 is a pro-inflammatory cytokine secreted
by monocytes, macrophages and fat cells. Studies have
shown that the level of blood circulating IL-6 is signifi-
cantly increased in obese subjects [34]. Adipose tissue is
a source of approximately 30% of this cytokine in the or-
ganism [35]. IL-6 participates in the development of insulin
resistance via different mechanisms. Firstly, this adipokine
decreases adiponectin secretion by adipose tissue. More-
over, it directly affects the insulin signal transduction path-
way in hepatocytes [36]. The mechanism of this action is
not completely understood, but it is believed that SOCS3
protein (suppressor of cytokine signal 3) may be involved.
SOCS3 probably inhibits the insulin-dependent autophos-
phorylation of insulin receptor [37]. Presented results
showed that secretion of this pro-inflammatory adipokine
by fat cells was strongly connected with their age, and was
the highest in old adipocytes (PID 16). n-3 PUFA have
been reported to have anti-inflammatory properties. Sur-
prisingly, in our study we found that EPA supplementation
increased IL-6 concentration in conditioned medium,
while DHA exerted an opposite effect. Similar impact of
investigated fatty acids was observed at all stages of cellular
maturation. Contrary results were obtained by other
Figure 6 Schematic presentation of the experiment with marked days in which material for analyses was collected.
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hana and co-workers observed that EPA treatment
(200 μM) increased secretion of IL-6 in differentiated
3T3-L1 cells [38]. On the other hand, Kalupahana and
co-workers found that 150 μM concentration of EPA in
incubation medium inhibited IL-6 release by adipocytes
[26]. These differences are hard to explain because in all
experiments the time of treatment was the same, and
the reaction of 3T3-L1 cells to n-3 PUFA treatment was
not dose-dependent. These discrepancies show that this
topic needs further investigation in the future. However,
the results of our study indicate that EPA and DHA are
able to modulate secretion of IL-6 not only in young
cells but also in ageing adipocytes.
In addition, we examined the content of polyunsatur-
ated fatty acids: EPA and DHA in cultured cells. The re-
sults obtained revealed that the uptake of investigated
fatty acids increased with age. On the other hand, the
percentage of EPA and DHA in relation to the total
quantity of fatty acids decreased with age in most cases.
The second observation correlated with age-dependant
differences in secretion of examined adipokines and
could at least partially explain the weaker effect of EPA
and DHA on endocrine functions of old cells in com-
parison with young and mature adipocytes.
Conclusions
Age is an important determinant of fat accumulation in
adipocytes and affects adipokines secretion by this type
of cells. Older adipocytes are more filled with fat, and re-
lease more pro-inflammatory factors. These observations
suggest that differentiated 3T3-L1 cells on later stages of
maturation can serve as a good experimental model for
studying obesity and inflammation in adipose tissue.
EPA and DHA did not affect the accumulation of fat
and lipolysis in 3T3-L1 cells, but significantly altered se-
cretion of adipokines. The influence of these fatty acids
on adipokines release by 3T3-L1 cells varied at different
stages of cellular maturation. Action of DHA seems to
be anti-inflammatory; however, on the basis of the data
obtained it was not possible to determine whether EPA
exerts anti- or pro-inflammatory properties. The effects
of evaluated fatty acids on endocrine function of adipo-
cytes were stronger in young cells than in mature andold ones, which could be related to lower percentage
content of n-3 PUFA in total fatty acids in old cells when
compared with young and mature cells.
Methods
Cell culture
3T3-L1 mouse embryo fibroblasts were purchased from
American Type Culture Collection (Rockville, MD USA)
and cultured in humidified atmosphere of 5% CO2, 95% air
at 37°C. The cells were maintained in a growth medium
containing the following components: Dulbecco’s modi-
fied Eagle’s medium (Sigma) with high glucose, 10% new-
born calf serum (NBCS, obtained from Invitrogen) and
1% penicillin-streptomycin (P/S, Sigma). Two days after
the cells reached confluence (post-induction day 0), differ-
entiation to adipocytes was initiated using differentiation
medium supplemented with: 1 μM dexamethasone (Sigma),
0.5 mM isobutylmethylxanthine (Sigma) and 10 μg/ml in-
sulin (Sigma). In differentiation medium 10% addition of
NBCS was also replaced with 10% fetal bovine serum (FBS,
GIBCO). After 2 days (post-induction day 2) fresh medium
containing only insulin was added for further 2 days. On
post-induction day 4 medium was replaced with DMEM
supplemented with 10% FBS and antibiotics. The cells were
maintained in this type of medium until fatty acid treat-
ment. Medium was change every two days.
Fatty acids treatments
On post-induction days (PID) 6, 10 and 14 differentiated
3T3-L1 adipocytes were cultured for 48 h in the presence
of 100 μM EPA, or 50 μM DHA complexed to albumin;
whereas, in control conditions only albumin was added to
the medium. Experimental media consisted of serum-free
DMEM, 1% FA-free bovine serum albumin (BSA), EPA/
DHA/albumin and antibiotics. Every fatty acid treatment
was preceded by 12-hour starvation in serum-free DMEM
supplemented with 1% FA-free BSA and antibiotics. On
PID 8, 12 and 16 conditioned media were collected and
stored at – 80°C until further analyses. The scheme of the
experiment is presented in Figure 6.
Oil Red O staining
The Oil Red O staining was used to confirm adipocytes dif-
ferentiation and measure triglycerides content in cells. After
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adipocytes were washed with cold phosphate-buffered sa-
line (PBS; pH 7.4) and fixed with 4% paraformaldehyde so-
lution in PBS for 30 minutes. Subsequently, cells were
washed twice in PBS and stained in Oil Red O working so-
lution (stock – water, 3:2) for 30 minutes. Then Oil Red O
was discarded and cells were washed with water 4 times.
Images of stained cells were taken using phase contrast
microscope (Olympus IX-70 microscope, Optical Co.,
Hamburg, Germany). Additionally, a quantitative measure-
ment of triglycerides was performed. Oil Red O was ex-
tracted from adipocytes by isopropanol and absorbance was
spectrophotometrically measured at 500 nm.
Preparation of fatty acid methyl esters
Cells were collected on PID 8, 12 and 16, and fatty acids
were extracted by a mixture of chloroform and methanol
(2:1). Chloroform – methanol was added to cell pellets,
and the samples were vortex-mixed for 15 min, and left
to form a bilayer. The aqueous phase was discarded, and
the organic layer was evaporated using nitrogen. Two
milliliters of 0.5 M NaOH in methanol was added, and
the samples were incubated for 1 hour at 85°C. Then the
samples were cooled on ice, and unsaponifiable lipids
were removed by extraction with hexane. The residue
was acidified to pH 2 with 4 M HCl, and the free fatty
acids were extracted with hexane. The solvent was evap-
orated under nitrogen, and fatty acids were esterified
with 2 M HCl in methanol for 45 minutes at 85°C.
When the samples were cooled down, fatty acid methyl
esters (FAME) were extracted with hexane.
GC-MS analysis
A Perkin Elmer model Clarus 500 selective mass de-
tector coupled to a model Clarus 500 GC was used.
FAME were separated on the GC with a ZB-5MSi
column (30 m × 0.25 mm ID ×1.00 μm film thickness,
Phenomenex USA) with the following conditions: helium
flow rate, 1 mL/min; initial oven temperature, 50°C, with
increase at 15°C/min to 280°C, and increase at 3°C/min to
a final temperature of 300°C and held for 3 minutes. The
expected retention times for EPA and DHA were: 20.35
and 22.34 min, respectively. Mass spectra of fatty acids
were acquired using electron impact ionization in total
ions current mode.
Glycerol measurements
Glycerol released into the media was quantified by com-
mercial glycerol test (Randox, cat. no. GY105) according
to manufacturer’s instructions.
Adipokines analysis
The concentration of adipokines in conditioned media
was measured using mouse-specific ELISA kits. Thefollowing adipokines were quantified: interleukin 6 (Dia-
clone, cat. no. 860.020.096), adiponectin (Biovendor, cat.
no. RD293023100R) and leptin (Mediagnost, cat. no.
E06). All analysis were performed according to manufac-
turer’s instructions.
Statistical analysis
All results are expressed as means ± SEM. Data were an-
alyzed by GraphPad PrismTM version 5.00 (GraphPad
Software, Inc., USA). The statistical significance of differ-
ences between groups was determined by one-way ana-
lysis of variance (One-way ANOVA) and Tukey’s
multiple-comparison post-test. The results were consid-
ered to be significant when the value of P was <0.05.
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